Evidence map›Paper›PMID 26916933›Full record

ArticleMalaria journal2016

Establishing research priorities for malaria elimination in the context of the emergency response to artemisinin resistance framework-the Cambodian approach.

Sara E Canavati, Harriet L S Lawford, Bayo S Fatunmbi, Dysoley Lek, Narann Top-Samphor, Rithea Leang, Arjen M Dondorp, Rekol Huy, Walter M Kazadi

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Malaria Parasites: The Great Escape.Frontiers in immunology · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Sara E CanavatiDepartment of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, 420/6 Rajvithi Road, Rajthevee, Bangkok, Thailand. s.canavatidelatorre@kellogg.oxon.org.
Harriet L S LawfordThe National Center for Parasitology, Entomology and Malaria Control, Ministry of Health, Phnom Penh, Cambodia. harrietlawford@gmail.com.
Bayo S FatunmbiEmergency Response to Artemisinin Resistance, WHO Representative Office in Cambodia, Penh Phnom Penh, Cambodia. fatunmbib@wpro.who.int.
Dysoley LekThe National Center for Parasitology, Entomology and Malaria Control, Ministry of Health, Phnom Penh, Cambodia. soleycnm@gmail.com.
Narann Top-SamphorEmergency Response to Artemisinin Resistance, WHO Representative Office in Cambodia, Penh Phnom Penh, Cambodia. tops@wpro.who.int.
Rithea LeangThe National Center for Parasitology, Entomology and Malaria Control, Ministry of Health, Phnom Penh, Cambodia. rithealeang@gmail.com.
Arjen M DondorpMahidol Oxford Tropical Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. arjen@tropmedres.ac.
Rekol HuyThe National Center for Parasitology, Entomology and Malaria Control, Ministry of Health, Phnom Penh, Cambodia. director@cnm.gov.kh.
Walter M KazadiEmergency Response to Artemisinin Resistance, WHO Representative Office in Cambodia, Penh Phnom Penh, Cambodia. kazadimulombow@wpro.who.int.
Documentation Center of Cambodia · KHMinistry of Health · KHMahidol Oxford Tropical Medicine Research Unit · THCambodia National Malaria Center · KH

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundCountries of the greater Mekong subregion have made a transition from malaria control to an aim for falciparum and vivax malaria elimination. The elimination of falciparum malaria will have to be achieved against a background of increasing artemisinin and multi-drug resistance. This ambitious goal requires an operational research (OR) agenda that addresses the dynamic challenges encountered on the path to elimination, which will need to be flexible and developed in close relation with the cambodian national programme for parasitology, entomology and malaria control (CNM). In Cambodia, a number of meetings with stakeholders were convened by the CNM and emergency response to artemisinin resistance (ERAR) hub, producing an initial list of priority OR topics. The process and outcome of these meetings are described, which could serve as a template for other countries in the region.

methodsA landscaping exercise was conducted to gather all past, on-going and planned malaria focussed OR activities conducted by the cambodian research consortium in Cambodia and categorized according to research theme. The six themes included (1) malaria epidemiology, surveillance and response, (2) malaria case management, (3) malaria vector control, (4) malaria behavioural issues, (5) malaria clinical studies, and (6) other vector-borne diseases (dengue, neglected tropical diseases, soil-transmitted helminths). The different themes were discussed in small focus groups, which made an initial prioritization list which was then presented to a plenary group for further discussion. This produced a list of research questions ranked according to priority.

resultsOR priorities produced by the thematic groups were discussed in the plenary meeting and given a priority score by group voting. A list of 17 OR questions were developed, finalized and listed, which included questions on surveillance, active case detection and treatment efficacy.

conclusionThis paper describes ERAR's work on supporting Cambodia's transition to malaria elimination by identifying national operational research priorities. ERAR has initiated and currently plays a critical role in the development of country specific research agendas for malaria elimination. The first example of this has been the described exercise in Cambodia, which could serve a template for setting OR priorities in the wider region.

Indexed as

AntimalarialsArtemisininsCambodiaDisease EradicationDrug Resistance, MultipleHealth PrioritiesHumansMalariaOperations ResearchPlasmodium falciparumPlasmodium vivaxAntimalarialsArtemisinins

Identifiers

PMID26916933
PMCPMC4766599
OpenAlexW2286108175

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.